BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 2017
View Archived Issues
Promentis Pharmaceuticals completes series C financing and elects new board members
Read More
Symproic approved in Japan for the treatment of opioid-induced constipation
Read More
Antiva raises series C financing to support development of ABI-1968
Read More
LAM Therapeutics closes series C financing
Read More
Takeda and MMV establish new joint research program in malaria
Read More
CARB-X funds projects to tackle antibiotic resistance
Read More
Calypso Biotech and EA Pharma enter CALY-001 license agreement
Read More
First patient dosed in phase II study of ARGX-113 in ITP
Read More
No statistically significant PT-specific antibody responses seen in phase I trial of Viaskin rPT
Read More
SRI International receives FDA clearance to evaluate novel oral formulation of Zn-DTPA
Read More
FDA grants orphan drug status to miRagen's MRG-106
Read More
NIAID initiates phase II/IIb study of DNA vaccine to protect against Zika virus infection
Read More
Munipharma's Mundesine capsules approved in Japan
Read More
Incyte gives updates on epacadostat combination studies
Read More
Saniona initiates phase IIa study of Tesomet in patients with Prader-Will syndrome
Read More
HMBD-001, a novel anti-ERBB3 antibody that inhibits tumor growth in preclinical models
Read More
XOMA-129 prevents hypoglycemia in minipigs
Read More
European Commission approves Tafinlar with Mekinist for BRAF V600-positive NSCLC
Read More
Espero Pharmaceuticals and Armetheon plan to merge and create Espero BioPharma
Read More
FDA grants regular approval and expanded indication to Pfizer's Ibrance
Read More
Opthea reports results from phase I/IIa trial of OPT-302 in wet AMD
Read More
Anti-HER2 scFv-Fc(Ser396Sec)/CN29 is a novel selenomab drug conjugate with activity in vivo
Read More
Kite completes rolling BLA submission for axicabtagene ciloleucel
Read More
SR-3306 study shows targeting JNK3 may improve Alzheimer's disease
Read More
Potential role of adaptive immune response in regulating ZIKV infection and preventing disease
Read More
Novel cyclin-dependent kinase inhibitors discovered at Dana-Farber Cancer Institute
Read More
Japanese approval for Narurapid and Narusus tablets to treat cancer pain
Read More
Janssen decides not to advance phase II study of daratumumab in NHL
Read More
Redx Pharma identifies novel antibacterial compounds
Read More
Janssen, Katholieke Universiteit Leuven patent dengue virus replication inhibitors
Read More